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Abstract: 14 
Various TRP channels act as polymodal sensors of thermal and chemical stimuli, but the 15 
mechanisms whereby chemical ligands impact on TRP channel gating are poorly 16 
understood. Here we show that AITC (allyl isothiocyanate; mustard oil) and menthol 17 
represent two distinct types of ligands at the mammalian cold sensor TRPM8. Kinetic 18 
analysis of channel gating revealed that AITC acts by destabilizing the closed channel, 19 
whereas menthol stabilizes the open channel, relative to the transition state. Based on 20 
these differences, we classify agonists as either type I (menthol-like) or type II (AITC-21 
like), and provide a kinetic model that faithfully reproduces their differential effects. We 22 
further demonstrate that type I and type II agonists have a distinct impact on TRPM8 23 
currents and TRPM8-mediated calcium signals in excitable cells. These findings provide 24 
a theoretical framework for understanding the differential actions of TRP channel 25 
ligands, with important ramifications for TRP channel structure-function analysis and 26 
pharmacology. 27 
Introduction: 28 
Neurons of the somatosensory system act as individually tuned sensory cells that convert 29 
specific thermal, mechanical and/or chemical stimuli into electrical signals, which are then 30 
conveyed to the central nervous system (Vriens et al., 2014). Within the somatosensory 31 
system, several members of the TRP superfamily of cation channels act as polymodal 32 
molecular sensors of both temperature, and a variety of endogenous and exogenous 33 
chemicals, including a plethora of plant-derived compounds (Clapham, 2003; Tominaga et al., 34 
1998; Voets et al., 2005; Vriens et al., 2014). Chemical activation of TRP channels in nerve 35 
endings of trigeminal or dorsal root ganglion neurons is generally believed to underlie typical 36 
chemesthetic sensations evoked by such plant-derived substances (Bandell et al., 2007), such 37 
as the burning heat evoked by capsaicin (the pungent substance in hot peppers), which acts as 38 
a selective agonist of the heat-activated TRPV1 (Caterina et al., 1997), and the cool sensation 39 
evoked by menthol (the cooling compound in mint plants), due to activation of the cold sensor 40 
TRPM8 (McKemy et al., 2002; Peier et al., 2002). Such TRP channel ligands are present in 41 
widely used foodstuffs and drugs (Nilius and Appendino, 2013), and are extensively used as 42 
pharmacological tools to study somatosensation and/or TRP channel function in vitro and in 43 
vivo (Julius, 2013). Yet, very little is known about the molecular and biophysical mechanisms 44 
of action of the various TRP channel ligands. 45 
We studied the agonist effects of AITC, also known as mustard oil, a pungent organosulphur 46 
compound derived from Brassica plants. AITC is responsible for the characteristic oral 47 
sensations that one experiences upon eating Dijon mustard or wasabi, which contain between 48 
5-30 mM of AITC (Uematsu et al., 2002). Whereas earlier work has firmly established that 49 
AITC activates TRPA1 and TRPV1 in nociceptor neurons, approximately 10% of dorsal root 50 
ganglion neurons remained AITC-responsive after combined genetic deletion these two TRP 51 
channels (Bandell et al., 2004; Bautista et al., 2006; Everaerts et al., 2011; Jordt et al., 2004). 52 
In this work we show that AITC excites this subset of somatosensory neurons via direct 53 
activation of TRPM8. Interestingly, a detailed biophysical analysis revealed that AITC 54 
activates TRPM8 by inducing a relative destabilization of the closed conformation relative to 55 
the transition state. This mode of action is fundamentally different from that of other known 56 
TRPM8 agonists such as menthol, which stabilize the open conformation relative to the 57 
transition state. Based on these results, we propose to classify TRPM8 agonists as either type I 58 
(menthol-like) or type II (AITC-like), and provide a kinetic model that accurately describes 59 
the differential actions of the two agonist types on channel gating kinetics. Finally, we 60 
illustrate that the two agonist types have distinct impact on TRPM8-mediated currents and 61 
calcium signals in excitable cells.  62 
Results: 63 
TRPM8-dependent responses to AITC in sensory neurons 64 
To investigate the origin of TRPV1- and TRPA1-independent AITC responses, we performed 65 
Ca2+ imaging experiments on dorsal root ganglion (DRG) neurons isolated from 66 
TRPV1/TRPA1 double knockout mice. In line with previous work (Everaerts et al., 2011), we 67 
found that a small fraction of these TRPV1/TRPA1-deficient neurons (55 out of 578; 9 %) 68 
showed a rapid and reversible increase in intracellular Ca2+ in response to 3 mM AITC 69 
(Figure 1A). These AITC-responsive cells consistently responded to menthol (54 out of 55; 70 
98%) (Figure 1A,B). In these cells, the responses to both AITC and menthol were fully 71 
inhibited by the TRPM8 antagonist AMTB, and recovered partially upon AMTB washout 72 
(Figure 1C). Taken together, these results indicate that TRPV1- and TRPA1-independent 73 
AITC responses in DRG neurons depend on the cold- and menthol-sensitive channel TRPM8. 74 
AITC activates heterologously expressed TRPM8 75 
To investigate the mechanisms underlying TRPM8-dependent AITC sensitivity in sensory 76 
neurons, we tested the effect of acute application of AITC on whole-cell currents in HEK293 77 
cells heterologously expressing human TRPM8. At room temperature, TRPM8 exhibits 78 
substantial activity, which can be recorded as an outwardly rectifying current (Figure 2A,B). 79 
Application of AITC at concentrations ≥300 μM caused a rapid and reversible increase in 80 
TRPM8 current (Figure 2A). The amplitude of the response increased with AITC 81 
concentration, with relatively stronger effects at negative voltages, but did not saturate at the 82 
highest concentration tested (10 mM; Figure 2C). At 3 and 10 mM AITC, activation was 83 
followed by a gradual decay of TRPM8 current, reducing current amplitude to levels below 84 
the basal level (Figure 2A,B). Following washout of 3 or 10 mM AITC after prolonged 85 
exposure, we observed an rapid initial decrease in current followed by a gradual restoration of 86 
the current to the basal level (Figure 2A), suggesting that the agonistic effect of AITC 87 
reverses more rapidly than the inhibitory effect. Rapid and reversible current responses to 88 
AITC were also observed in cell-free inside-out patches from human TRPM8-expressing 89 
HEK293 cells, indicating that the effect of AITC on TRPM8 is membrane-delimited (Figure 90 
2D,E). 91 
It has been put forward that AITC induces trafficking of TRPA1 to the plasma membrane 92 
(Schmidt et al., 2009). To test whether AITC-induced activation of TRPM8 also involves 93 
rapid translocation of the channel towards the plasma membrane, we expressed human 94 
TRPM8 coupled with mCherry at its C terminus (TRPM8-mCherry), and performed total 95 
internal reflection fluorescence (TIRF) microscopy to monitor potential AITC-induced 96 
transport of TRPM8 towards the plasma membrane. We have recently shown that TRPM8-97 
mCherry is fully functional, and can be used to track cellular TRPM8 transport (Ghosh et al., 98 
2016). As shown in Figure 2F,G, application of 3 mM AITC had no detectable effect on the 99 
TRPM8-mCherry fluorescence in the close vicinity of the plasma membrane. mCherry 100 
fluorescence amounted to 99 ± 1 % and 102 ± 2 % of the pre-AITC level after 5 and 50 s of 101 
AITC application, respectively. Since the onset of current activation by AITC was very rapid, 102 
with maximal current achieved within ~2 s (Figure 2A,D), we can exclude a significant 103 
contribution of trafficking to the acute agonistic effect of AITC on TRPM8.  104 
Distinct effects of AITC and menthol on gating kinetics 105 
To investigate the mechanism of the agonistic effect of AITC in more detail, we recorded 106 
TRPM8 currents during voltage steps ranging from -140 to +220 mV, both in control 107 
conditions and immediately upon application of AITC (Figure 3A). Analysis of the steady-108 
state conductances revealed that AITC has little or no effect on the maximal conductance at 109 
strongly depolarizing potentials, but shifts the voltage-dependent activation curves towards 110 
more negative voltages in a concentration-dependent manner (Figure 3B,C). Such ligand-111 
induced shifts in the voltage-dependent activation curve have been shown earlier to describe 112 
the effects of agonists on TRP channels, including the effect of menthol on TRPM8 (Voets et 113 
al., 2004; Voets et al., 2007) (Janssens and Voets, 2011).  114 
However, when analyzing the kinetics of TRPM8 current activation/deactivation during 115 
voltage steps in more detail, we observed a remarkable difference between the effects of 116 
menthol and AITC. This is illustrated in Figure 4A, which provides a comparison of currents 117 
in the absence of ligands and in the presence of either 3 mM AITC or 30 μM menthol, 118 
concentrations that provoke similar steady-state TRPM8 current amplitudes at the end of the 119 
voltage steps. In the presence of AITC we observed a clear acceleration of the gating kinetics 120 
upon depolarization to +120 mV, whereas the current relaxation kinetics upon repolarization 121 
to -80 mV were not markedly altered. In stark contrast, in the presence of menthol we found a 122 
pronounced slowing of the kinetics of current relaxation, most noticeable upon repolarization 123 
to -80 mV (Figure 4A,B).  124 
To quantify the differences in gating kinetics in more detail, we fitted exponential functions to 125 
the current time courses during voltage steps. In line with earlier work, we found that in the 126 
absence of ligands the time courses at +120 and -80 mV were generally well fitted by a mono-127 
exponential function (Figure 4A,B; Figure 4 – Figure Supplement 1), yielding the time 128 
constants of current relaxation at both potentials (τ+120mV and τ-80mV). In the presence of 3 mM 129 
AITC, the time courses remained well fitted by a mono-exponential function, and the 130 
accelerated kinetics were reflected in a reduction of τ+120mV compared to control, whereas τ-131 
80mV was unaltered (Figure 4A,B,E). In contrast, the relaxation kinetics in the presence of 30 132 
μM menthol were consistently slower than in control and were no longer mono-exponential: 133 
at least two exponential terms were required to accurately describe the current time course at 134 
+120 (τ+120mV,fast and τ+120mV,slow) and -80 mV (τ-80mV,fast and τ-80mV,slow) (Figure 4A,B,F). 135 
These distinct effects of AITC and menthol on the current relaxation kinetics of TRPM8 were 136 
observed over a broad concentration range (Figure 4C-F). Other known TRPM8 agonists, 137 
including thymol, icilin, and linalool, act in a similar manner as menthol, slowing down the 138 
kinetics of activation and deactivation, albeit less pronounced (Figure 4 – Figure Supplement 139 
2).  140 
Defining Type I and Type II agonists 141 
Based on these results, we propose that TRPM8 agonists be classified into two types based on 142 
their effect on the gating kinetics: Type I (menthol-like) agonists induce a slowing of the 143 
gating kinetics, which is most prominently observed as slowly deactivating tail currents 144 
following repolarization, whereas Type II (AITC-like) agonists cause an acceleration of the 145 
kinetics of channel activation upon depolarization, with little or no effect on the kinetics of 146 
deactivating tail currents (Figure 4). The differential effects of the two ligand types on the 147 
gating kinetics suggest that they act on different conformational states of the channel during 148 
the gating process. In particular, the characteristic slowly decaying tail currents upon 149 
repolarization in the presence of menthol indicate that menthol impedes voltage-dependent 150 
channel deactivation, which points at a stabilization of the channel in an open conformation. 151 
Oppositely, the faster current relaxation upon depolarization in the presence of AITC 152 
indicates that AITC accelerates voltage-dependent channel activation, which points at a 153 
destabilization of the channel in a closed conformation. 154 
To further pinpoint the mechanistic basis of different effects of Type I and Type II agonists on 155 
channel gating kinetics, we built on a previously described voltage-dependent Monod-156 
Wyman-Changeux (MWC) model that was initially developed to describe the concerted 157 
actions of Ca2+ and voltage on the gating of large conductance Ca2+-activated potassium (BK) 158 
channels (Cox et al., 1997). We have shown earlier that this model can accurately describe the 159 
effect of menthol, voltage and temperature on steady-state TRPM8 currents (Janssens and 160 
Voets, 2011). Moreover, based on analysis of channel chimeras with different combinations 161 
of wild type and mutated menthol binding sites, it was found that a single TRPM8 channel 162 
can bind up to four ligand molecules, each subunit having and ligand binding site with an 163 
affinity Kd (in the closed state), and that every bound ligand shifts the equilibrium between 164 
the closed and open channel by a similar extent (Janssens and Voets, 2011). The energetic 165 
effect of ligand binding can be quantified as ΔΔGligand, which represents the change of the 166 
difference in Gibbs free energy between the closed and open state of the channel (ΔG) upon 167 
binding of one ligand molecule to one of the four subunits. In the case of an agonist, ΔΔGligand 168 
< 0, which implies that the open state becomes more stable relative to the closed state. As 169 
illustrated by the energy diagrams in Figure 5A, a negative ΔΔGligand can be the result of a 170 
ligand-induced relative stabilization of the open state, destabilization of the closed state, or a 171 
combination of both, taking the transition state as the reference. In the case of a relative 172 
stabilization of the open state, the energy barrier for the transition from open to closed will 173 
become higher, which would lead to slower closing rates, as seen with the Type I agonists 174 
(Figure 5A). Oppositely, relative destabilization of the closed state will reduce the energy 175 
barrier for the transition from closed to open, which would be reflected in faster opening rates, 176 
as seen with the Type II agonist AITC (Figure 5 – Figure Supplement 1).  177 
We performed global fits of the MWC model to the experimental current time courses 178 
obtained in individual cells during voltage steps in both the absence and presence of different 179 
concentrations of AITC or menthol. Values for Kd,menthol, ΔΔGmenthol, Kd,AITC and ΔΔGAITC 180 
were obtained from shifts in the steady-state voltage-dependent activation curves (Janssens 181 
and Voets, 2011). Note that values for the on rates for ligand binding (kon) were determined 182 
from the fits, in contrast to earlier work in BK channels were Ca2+ binding rates were assumed 183 
to be diffusion-limited (Cox et al., 1997). Off rates (koff) were constrained by the Kd and on 184 
rates. Importantly, we obtained excellent fits to the experimental data when we set fixed that 185 
menthol binding acts exclusively by stabilization the open state, while AITC acts by 186 
destabilization of the closed state (Figure 5B,C). Model parameters obtained from the fits are 187 
listed in Table 1. Gratifyingly, the model accurately predicts the concentration-dependent 188 
effects of AITC and menthol on TRPM8, including the mono-exponential time constants in 189 
the presence of different AITC concentrations, as well as the bi-exponential relaxation 190 
kinetics in the presence of menthol, respectively (Figure 5D,E; Figure 4E,F; Figure 4 – Figure 191 
Supplement 1). Based on these results, we propose that AITC represents the first example of a 192 
type II TRPM8 agonist, acting primarily by destabilizing the closed channel, which contrasts 193 
to the Type I agonists, such as menthol, icilin, thymol and linalool, which primarily stabilize 194 
the open channel. 195 
We also tested the combined effect of AITC and menthol on the kinetics of   TRPM8 196 
activation and deactivation. In line with the above, application of 50 μM menthol results in 197 
slower activation and deactivation kinetics, due to the stabilization of the open state (Figure 5 198 
– Figure Supplement 2). Addition of 3 mM AITC in the continued presence of menthol 199 
resulted in faster activation kinetics, without affecting the time course of deactivation (Figure 200 
5 – Figure Supplement 2). These results are in line with the predictions of the MWC model, 201 
assuming that Type I and Type II agonists can act simultaneously and independently, 202 
resulting in both stabilization of the open and destabilization of the closed state (Figure 5 – 203 
Figure Supplement 2).  204 
Type I versus Type II agonists: effect during action potentials 205 
In the context of a sensory neuron, activation of ion channels such as TRPM8 causes influx of 206 
Na+ and Ca2+, which depolarizes the membrane and, when the threshold is reached, causes 207 
action potential generation (Vriens et al., 2014). The differential effects of Type I and Type II 208 
agonists on the gating kinetics of TRPM8 suggest that they may have distinct effects on 209 
TRPM8-mediated currents and calcium signals during rapid neuronal action potentials. To 210 
investigate this possibility, we measured TRPM8 currents evoked by voltage waveforms 211 
mimicking action potentials in sensory neurons in the presence of AITC (3 mM) or menthol 212 
(30 µM). Note that, at a physiological holding potential of -60 mV, these concentrations 213 
resulted in comparable steady-state inward current amplitudes (Figure 6A). In response to the 214 
action potential waveforms, the current in the presence of AITC mainly manifested during the 215 
upstroke phase, and rapidly deactivates upon action potential repolarization. In comparison, in 216 
the presence of menthol, the peak outward current is smaller but a more prominent inward 217 
TRPM8 current is observed during the repolarization phase of the action potential (Figure 6A-218 
C). These differential effects of AITC and menthol on TRPM8 currents during an action 219 
potential are fully in line with the predictions of the MWC model for type I versus Type II 220 
agonists (Figure 6A). We also compared the cumulative influx and efflux of charge during a 221 
1-s train of action potential waveforms at 8 Hz, a typical firing rate of cold-sensitive neurons 222 
(Orio et al., 2012). As illustrated in Figure 6D,E, net charge influx is larger in the presence of 223 
menthol, whereas net charge efflux is larger in the presence of AITC.  224 
Under normal physiological conditions, inward TRPM8 current is partially carried by Ca2+ 225 
ions (McKemy et al., 2002; Peier et al., 2002). Since our results indicated substantial 226 
differences in charge influx during action potentials between Type I and Type II agonists, we 227 
expected that menthol and AITC may show differential efficacy in evoking Ca2+ transients in 228 
excitable versus non-excitable cells. To test this, we compared the relative responses to 229 
menthol and AITC in TRPM8-expressing mouse sensory neurons versus (non-excitable) 230 
HEK293 cells heterologously expressing TRPM8. For these latter experiments, we used 231 
HEK293 cells transiently expressing the mouse TRPM8 orthologue, and first tested current 232 
responses to AITC. Like its human orthologue, mouse TRPM8 was rapidly activated by 233 
AITC, and the difference in gating kinetics in the presence of AITC versus menthol was also 234 
observed (Figure 7 - Figure Supplement 1). However, interestingly, AITC-induced current 235 
inhibition was much less pronounced in mouse TRPM8 compared to the human orthologue 236 
(Figure 7 - Figure Supplement 2): at the end of a 60-s application of 3 mM AITC, mouse 237 
TRPM8 current amounted to 88 ± 6 % (n=8) of the peak current, compared to 21 ± 5 % in the 238 
case of human TRPM8 (n=7; p = 0.00004). A further analysis of this species difference in 239 
AITC-induced inhibition is provided in Figure 7 - Figure Supplement 2.  240 
To specifically analyze TRPM8-mediated responses to AITC and menthol in mouse sensory 241 
neurons, we used TRPA1/TRPV1 double knockout mice, only examined cells that showed 242 
robust responses to both agonists, and controlled that these responses were fully inhibited in 243 
the presence of AMTB, as outlined in Figure 1. In these cells, we found that the amplitudes of 244 
Ca2+ transients evoked by a 60-s-long applications of 3 mM AITC were on average ~30% 245 
smaller than those evoked by 30 µM menthol (Figure 7A,D). Likewise, the peak rate of 246 
calcium rise, which represents a measure for the maximal inward calcium current, was 247 
consistently smaller in response to AITC than to menthol in neurons (Figure 7A,D). 248 
Interestingly, we observed an opposite potency of the same concentrations of menthol and 249 
AITC in HEK cells expressing mouse TRPM8: AITC evoked larger calcium increases and 250 
with a higher peak rate of calcium rise than did menthol (Figure 7B,D). Moreover, if action 251 
potential firing in the TRPA1/TRPV1-deficient sensory neurons was blocked using 252 
tetrodotoxin (TTX; 1 μM), we found a similar ratio of AITC versus menthol responses as in 253 
HEK cells (Figure 7C,D), with AITC being slightly more potent than menthol. Taken 254 
together, these data provide further support for the notion that, compared to Type II agonists 255 
(e.g. AITC), Type I agonists (e.g. menthol) are more potent in evoking calcium influx in 256 
excitable cells, due to enhanced calcium influx during the prolonged inward tail currents 257 
following action potentials. In cells that do not fire action potentials, rapid changes in 258 
membrane potential are not expected, and hence the kinetic differences between the two types 259 
of agonists will not affect calcium signals.  260 
Discussion: 261 
While there are already numerous natural and synthetic agonists known for TRPM8 (Almaraz 262 
et al., 2014), our results demonstrate that AITC is an atypical agonist, with a mode of action 263 
that is fundamentally different from that of all other known TRPM8-activating stimuli. 264 
Activation of TRPM8 by cooling or by known agonists such as the natural compounds 265 
menthol, thymol and linalool, and the synthetic agonists such as icilin and halothane, is 266 
associated with a slowing of the kinetics of voltage-dependent channel gating (Vanden Abeele 267 
et al., 2013; Voets et al., 2004; Voets et al., 2007). This slowing of the gating kinetics can be 268 
directly explained by a stabilization of the open channel relative to the transition state, as we 269 
illustrated in this work for menthol and elsewhere for cooling (Voets et al., 2004). In clear 270 
contrast, activation of TRPM8 by AITC resulted in an acceleration of the kinetics of voltage-271 
dependent gating, and we show here that this can be fully explained by a mechanism where 272 
AITC leads to a relative destabilization of the closed conformation relative to the transition 273 
state. Based thereon, we propose that TRPM8 agonists can be classified as either Type I, 274 
causing a relative stabilization the open state, or Type II, causing a relative destabilization  the 275 
closed state, and we provide a kinetic voltage-dependent Monod-Wyman-Changeux-type 276 
model that faithfully reproduces their differential agonist effects. Such classification may also 277 
be extended to activating ligands of other voltage- and ligand-sensitive TRP channels. For 278 
instance, published current traces suggest that activation of TRPV1 by capsaicin or low pH is 279 
associated with faster activation time courses upon depolarization (Aneiros et al., 2011; Voets 280 
et al., 2004), classifying them as Type II ligands, whereas the activating effects of 281 
phosphatidylinositol-4,5-bisphosphate (PIP2) or lysophosphatidic acid are associated with 282 
slower activation and longer deactivating tails upon repolarization, classifying them a Type I 283 
agonists (Nieto-Posadas et al., 2012; Ufret-Vincenty et al., 2015).  284 
The classification of activating ligands as either Type I or Type II is useful for several 285 
purposes. First, this information can provide important insights into ligand-induced structural 286 
rearrangements during channel gating, and may help interpreting ligand-bound channel 287 
structures. Indeed, our results indicate that Type II ligands such as AITC reduce the difference 288 
Gibbs free energy between the closed state and the transition state (ΔGα†), without affecting 289 
the difference Gibbs free energy between the open state and the transition state (ΔGβ†). This 290 
suggests that the AITC-induced conformational change at its binding site occurs early in the 291 
gating process, prior to the main close-open transition. Oppositely, Type I ligands such as 292 
menthol cause an increase in ΔGβ†, without affecting ΔGα†. This indicates that the menthol-293 
induced conformational change at its binding sites occurs later than the main close-open 294 
transition. This analysis and interpretation is reminiscent of the rate-equilibrium free-energy 295 
relationship (REFER) approach, which has used to evaluate the effects of perturbations (e.g. 296 
ligands or mutations) on the equilibrium of reactions, including the gating of ion channels 297 
such as the nicotinic acetylcholine receptor and CFTR (Grosman et al., 2000; Sorum et al., 298 
2015). In REFER, the effect of a family of perturbations on channel gating is quantified using 299 
the ϕ-value, which is the slope of a plot of the logarithm of the opening rate (log α) versus the 300 
log of the gating equilibrium constant (log Keq), where Keq is the ratio of the opening (α) and 301 
closing (β) rate (Keq = α/β) (Auerbach, 2007). In the case of type I ligands, ligand binding 302 
affects the equilibrium solely by decreasing β, yielding ϕ = 0. Following the REFER theorem, 303 
this indicates late movement (Auerbach, 2007). Type II ligands affect the equilibrium entirely 304 
by affecting α, yielding ϕ = 1, indicating early movement. We also found that the effects of 305 
simultaneously applied menthol and AITC on channel gating are well described assuming 306 
independent binding and additive effects on the gating equilibria, which further supports the 307 
notion that type I and type II ligands act at distant binding sites with different timing for 308 
conformational changes.  309 
Second, based on our kinetic fits, we obtained estimates for the on rates for ligand binding to 310 
TRPM8. For example, for menthol binding we obtained a kon of 0.55 μM-1s-1, which is well 311 
below the diffusion-limited rate (>100 μM-1s-1), and also one order of magnitude or more 312 
lower than binding rates for ligands to synaptic ligand-gated channels, such as the ionotropic 313 
receptors for glutamate (kon ≈ 5 μM-1s-1) (Clements and Westbrook, 1991), ATP (kon ≈ 12 μM-314 
1s-1) (Bean, 1990) or acetylcholine (kon ≈ 60 μM-1s-1) (Sine et al., 1990). The relatively slow 315 
ligand equilibration kinetics for menthol are in line with the distinct structural properties of 316 
ligand binding sites in TRP channels compared to these classical ionotropic receptors. Indeed, 317 
whereas binding sites for glutamate, ATP and acetylcholine are located extracellularly (Hille, 318 
2001), directly accessible from the aqueous phase, the binding site for menthol is located in a 319 
hydrophobic domain in between the transmembrane helices (Bandell et al., 2006; Voets et al., 320 
2007). The observation that current relaxation time courses of TRPM8 in the presence of 321 
menthol become multi-exponential is then a direct consequence of the slow equilibration rate 322 
of menthol with its binding site in comparison to the transition rates between closed and open 323 
channel conformations.  324 
Finally, we showed that differential effect on voltage-dependent gating of Type I and II 325 
agonists is reflected in distinctive TRP channel-mediated currents during rapid changes in 326 
membrane voltage, for instance during an action potential in a sensory neuron. Indeed, as 327 
predicted by our model, the AITC-induced TRPM8 current during a typical action potential 328 
waveform mainly manifest during the upstroke phase, and rapidly deactivates upon action 329 
potential repolarization. In contrast, an equipotent concentration of menthol (i.e. a 330 
concentration of menthol provoking a similar steady-state current) results in a less outward 331 
current but more prominent activation of inward TRPM8 current during the repolarization 332 
phase following an action potential, and thus leads to more Ca2+ influx via TRPM8. In line 333 
herewith, we found that inhibiting action potential firing using TTX has a more profound 334 
effect on menthol-induced responses than on AITC-induced responses in sensory neurons. 335 
These findings illustrate the importance of evaluating the mode of action of ligands on 336 
voltage-dependent TRP channels, especially when extrapolating results from non-excitable 337 
heterologous expression systems to physiological effects in excitable cells such as neurons, 338 
cardiomyocytes or pancreatic beta cells.  339 
Using the voltage-dependent Monod-Wyman-Changeux-type model, we assumed that for any 340 
number of bound ligands the transition between closed and open channel conformation is a 341 
one-step process, determined by forward and backward rates αi and βi. Whereas this 342 
assumption is in line with the mono-exponential kinetics we generally observed in our 343 
experiments in the absence of ligands (Voets et al., 2004), it is probably a simplification of the 344 
full gating intricacies of TRPM8, and models with one or more closed-closed transitions 345 
preceding channel opening have been proposed (Fernandez et al., 2011; Raddatz et al., 2014). 346 
Nevertheless, even when using such more complex models, the ligands’ effects on TRPM8 347 
gating kinetics can only be explained assuming that Type II ligands cause acceleration of the 348 
gating transition(s) towards the open state, whereas Type I ligands slow down the backward 349 
rate(s) from the open state. 350 
Our results demonstrate that TRPM8 underlies the residual TRPA1- and TRPV1-independent 351 
responses to AITC in mouse sensory neurons. Under our experimental conditions, activation 352 
of TRPM8 by AITC only occurred in the high micromolar to millimolar concentration range. 353 
As such, TRPM8 is about two orders of magnitude less sensitive to AITC than TRPA1, for 354 
which concentrations for half-maximal activation of 5-50 µM have been reported (Bandell et 355 
al., 2004; Everaerts et al., 2011; Jordt et al., 2004), but comparable to TRPV1, for which a 356 
concentration for half-maximal activation of 3 mM was found at room temperature (Everaerts 357 
et al., 2011). These findings are in line with in vitro experiments in sensory neurons, showing 358 
that AITC concentrations  ≤100 µM evoke responses that are strictly TRPA1-dependent 359 
(Bautista et al., 2006; Everaerts et al., 2011), whereas higher concentrations can also evoke 360 
TRPA1-independent responses mediated by TRPV1 or TRPM8. AITC is extensively used in 361 
in vivo experiments to induce pain and inflammation (Julius, 2013). In such assays, 362 
experimental solutions that are injected or topically applied typically contain AITC at 363 
concentrations between 10 and 100 mM (Bautista et al., 2006; Caterina et al., 2000). Whereas 364 
earlier studies have clearly shown that pain and inflammatory responses under such 365 
experimental conditions are largely mediated by TRPA1 and TRPV1 (Bautista et al., 2006; 366 
Everaerts et al., 2011; Kwan et al., 2006), our present results suggest that also TRPM8-367 
positive sensory nerve endings may become activated at these AITC doses. Since activation 368 
of TRPM8-expressing neurons can cause analgesia in animal models of acute and chronic 369 
pain (Liu et al., 2013; Proudfoot et al., 2006), the effects of AITC on TRPM8 that we describe 370 
here need to be taken into account when using AITC as a proalgesic and/or proinflammatory 371 
agent. TRPM8 may contribute to the complex psychophysical effects that one experiences 372 
upon eating spices containing millimolar concentrations of AITC such as mustard or wasabi 373 
(Nilius and Appendino, 2013). In line herewith, a transient increase in cold sensitivity was 374 
observed upon application of 100 mM AITC on the tongue of human volunteers (Albin et al., 375 
2008). Although speculative, this may correlate with the transient activation followed by 376 
channel inhibition that we observed in human TRPM8.  377 
In voltage-gated ion Na+, K+ and Ca2+ channels, ligand modulators have since decades been 378 
classified based on their distinct state-dependent effects on channel gating (Hille, 2001), and 379 
this mechanistic insight has been key to understanding their physiological impact in for 380 
instance neurons and cardiac cells (Sack and Sum, 2015). In this study, we demonstrate for 381 
the first time the existence of two types of agonists with distinct state-dependent effects for a 382 
member of the TRP superfamily, the cold-sensitive TRPM8, and provide a paradigm for their 383 
differential effects in sensory neurons. We argue that establishing the state-dependent mode of 384 
action of (ant)agonists of this and other TRP channels will be essential to clarify their 385 
physiological actions as well as to understand their impact on conformational changes in the 386 
channel molecule.  387 
  388 
Materials and Methods: 389 
Cells and transfection 390 
HEK293 were grown in DMEM containing 10% (v/v) fetal calf serum, 4 mM L-alanyl-L-391 
glutamine, 100 U ml–1 penicillin and 100 μg ml–1 streptomycin at 37 ºC in a humidity 392 
controlled incubator with 10% CO2. For patch-clamp and calcium imaging, cells were 393 
transiently transfected with different human (NM024080) or mouse (NM134252) TRPM8 394 
constructs cloned in the bicistronic pCAGGSM2-IRES-GFP vector using TransIT-293 395 
transfection reagent (Mirus). Mutations and chimeras were made using the PCR-overlap 396 
technique, and verified by Sanger sequencing (LGC-genomics, Germany). Chimeras were 397 
made by swapping the N termini (amino acids 1-336) or C termini (amino acids 993-1004) 398 
between the orthologues. For TIRF imaging, we used human TRPM8 linked with mCherry at 399 
its C-terminal end (Ghosh et al., 2016). 400 
Trigeminal ganglia (TGs) of 10-16-week-old female Trpv1-/-/Trpa1-/- mice were isolated after 401 
CO2 euthanasia. Bilateral TGs were collected and digested with 1 mg/ml collagenase and 2.5 402 
mg/ml dispase dissolved in ‘basal medium’ (Neurobasal A medium supplemented with 10% 403 
FCS) (all from Gibco/Life Technologies, Gent, Belgium) at 37 °C for ca. 45-60 min. Digested 404 
ganglia were gently washed once in ‘basal medium’ and twice in ‘complete medium’ 405 
(Neurobasal A medium supplemented with 2% B27 (Invitrogene/Life Technologies), 2 ng/ml 406 
GDNF (Invitrogen/Life Technologies) and 10 ng/ml NT4 (Peprotech, London, UK)) and 407 
mechanically dissociated by mixing with syringes fitted with increasing needle gauges. 408 
Neurons were seeded on poly-L-ornithine/laminin-coated glass bottom chambers (Fluorodish 409 
WPI, Hertfordshire, UK) and cultured at 37 °C in complete medium overnight. These 410 
experiments were approved by the KU Leuven Ethical Committee Laboratory Animals under 411 
project number P192/2014. 412 
Patch-clamp 413 
Between 16 and 24 hours after transfection, currents were recorded in the whole-cell or 414 
inside-out configurations of the patch-clamp technique using an EPC-9 amplifier and PULSE 415 
software (HEKA Elektronik). Data were sampled at 5-20 kHz and digitally filtered off-line at 416 
1-5 kHz. In the whole-cell mode, between 70 and 90% of the series resistance was 417 
compensated, and recordings where the estimated voltage error due to uncompensated series 418 
resistance exceeded 10 mV were excluded from analysis. Whole-cell recordings were 419 
performed using an intracellular solution containing (in mM) 150 NaCl, 5 MgCl2, 5 EGTA 420 
and 10 HEPES, pH 7.4. The extracellular solution contained (in mM) 150 NaCl, 1 MgCl2 and 421 
10 HEPES, pH 7.4. In inside-out recordings, the extracellular solution was used as pipette 422 
solution, and ligands were included in the intracellular bath solution. 423 
Calcium imaging: 424 
For intracellular Ca2+ measurements, cells were incubated with 2 µM Fura-2 acetoxymethyl 425 
ester for 30 minutes at 37 °C. The fluorescent signal was measured during alternating 426 
illumination at 340 and 380 nm using either an Olympus Cell^M or Nikon Eclipse Ti 427 
fluorescence microscopy system. The standard extracellular solution used in ratiometric 428 
[Ca2+]i measurements contained (in mM) 150 NaCl, 5 KCl, 2 CaCl2, 1.5 MgCl2, and 10 429 
HEPES, pH 7.4. 430 
TIRF imaging 431 
TIRF images were acquired using a through-the-lens TIRF system that was built around an 432 
inverted Axio Observer.Z1 microscope equipped with a X-100 oil objective numerical 433 
aperture (NA)=1.45 (Zeiss), a Hamamatsu Orca-R2 camera, and using a 561-nm laser. Time 434 
series of images at 1-s intervals were recorded. Constant focus was maintained using the 435 
Definite Focus module (Zeiss). The TIRF angle was set to achieve an evanescent field with a 436 
characteristic penetration depth (i.e., the distance in the z direction over which the intensity 437 
declines e-fold) of 90 nm. Cells on 25-mm glass coverslips were placed in a custom-made 438 
chamber and imaged at 25°C. 439 
Chemicals 440 
Chemicals were obtained from Sigma, unless indicated otherwise. AITC, menthol, thymol, 441 
linalool were dissolved in ethanol to obtain 1-M stock solutions. Icilin was dissolved in 442 
DMSO to obtain a 50-mM stock solution. Tetrodotoxin (TTX; from Alomone labs) was 443 
dissolved in acetate buffer at a concentration of 31 mM. 444 
Modeling and fitting 445 
As a starting point to model the gating of TRPM8 in the absence and presence of ligands, we 446 
built on our earlier work describing the effects of temperature and menthol on steady-state 447 
TRPM8 currents (Janssens and Voets, 2011; Voets, 2012; Voets et al., 2004; Voets et al., 448 
2007). In the absence of ligands, the transition between the closed and open conformation of 449 
the channel is determined by the opening and closing rates: 450 
ߙ଴ =  ௞್்௛ ݁ି
Δಸഀ಩
ೃ೅     (Eq.1) 451 
and 452 
ߚ଴ =  ௞್்௛ ݁ି
Δಸഁ಩
ೃ೅ ,    (Eq.2) 453 
where kb is the Boltzmann constant (1.38 × 10-23 J K-1), T the absolute temperature, h the 454 
Planck constant (6.63 × 10-34 J s), R the universal gas constant (8.314 × J K-1 mol-1) and κ the 455 
transmission coefficient, whose value for the studied processe is unknown. Δܩ଴ఈற (Δܩ଴ఉற) 456 
represents the difference in free energy between closed (open) state and the transition state of 457 
the non-liganded channel (see Figure 5), and depend on temperature and voltage (V) 458 
according to: 459 
Δܩఈற =  Δܪఈற − ܶΔܵఈற − 0.5ݖܨܸ    (Eq.3) 460 
and 461 
Δܩఉற =  Δܪఉற − ܶΔܵఉற + 0.5ݖܨܸ.    (Eq.4) 462 
Δܪ଴ఈற and Δܪ଴ఉற represent the differences in enthalpy and Δܵ଴ఈற and Δܵ଴ఉற the differences in 463 
entropy between, respectively, the closed and open state and the transition state, z the gating 464 
charge, and F the Faraday constant (96485 C mol-1). In our experiments, temperature was kept 465 
constant at 23°C, yielding: 466 
Δܩఈற =  Δܩ଴ ௠௏ఈற − 0.5ݖܨܸ    (Eq.5) 467 
and 468 
Δܩఉற =  Δܩ଴ ௠௏ఉற + 0.5ݖܨܸ.    (Eq.6) 469 
In the absence of ligands, the voltage-dependent opening and closing rates are then given by: 470 
ߙ଴(ܸ) = ߙ଴(0) × ݁
బ.ఱ౰ూ౒
ೃ೅      (Eq.7) 471 
and 472 
ߚ଴(ܸ) = ߚ଴(0) × ݁
షబ.ఱ౰ూ౒
ೃ೅ ,     (Eq.8) 473 
where ߙ଴(0) and ߚ଴(0) represent the opening and closing rates at 0 mV. 474 
As evidenced in earlier work (Janssens and Voets, 2011), we consider that TRPM8 has 4 475 
independent and energetically equivalent ligand binding sites (i.e. one per subunit), with an 476 
affinity Kd of the open channel determined by ligand-channel association and dissociation 477 
rates kon and koff (Kd = koff/kon). The energetic effect of ligand binding on steady-state channel 478 
equilibrium can be quantified as ΔΔGligand, which represents the change of the difference in 479 
Gibbs free energy between the closed and open state of the channel (ΔG) upon binding of one 480 
ligand molecule to one of the four subunits. Values for Kd,menthol, ΔΔGmenthol, Kd,AITC and 481 
ΔΔGAITC were obtained from concentration-dependent changes in the midpoint of the steady-482 
state voltage-dependent activation curves (ΔV1/2), according to:  483 
∆ ଵܸ/ଶ = − ோ்௭ி ln
൬ଵା[ಽ]಼೏൰
ర
൬ଵା[ಽ]಼೏×ୣ୶୮ 
∆∆ಸ
ೃ೅ ൰
ర.    (Eq.9) 484 
Since saturating effects of AITC could not be obtained at the highest concentration tested (10 485 
mM; on the limits of solubility), values for Kd,AITC and ΔΔGAITC should be considered as 486 
approximative. 487 
In the presence of a Type I agonist such as menthol, ligand binding stabilizes the open state, 488 
without affecting the closed or transition states (Figure 5 and Figure 5 – Figure Supplement 489 
1). Therefore, the opening rate of a channel with i bound ligands remains unaltered 490 
ߙ௜(ܸ) = ߙ଴(ܸ),    (Eq.10) 491 
whereas the closing rate becomes slower for each bound ligand, 492 
ߚ௜(ܸ) = ߚ଴(ܸ) × ݁ି
೔×∆∆ಸ೗೔೒ೌ೙೏
ೃ೅ .    (Eq.11) 493 
In the presence of a Type II agonist such as AITC, ligand binding destabilizes the closed state, 494 
without affecting the open or transition states (Figure 5 and Supplementary Figure 2) . 495 
Therefore, the closing rate of the channel remains unaltered 496 
ߚ௜(ܸ) = ߚ଴(ܸ),   (Eq.12) 497 
whereas the opening rate becomes faster for each bound ligand, 498 
ߙ௜(ܸ) = ߙ଴(ܸ) × ݁
೔×∆∆ಸ೗೔೒ೌ೙೏
ೃ೅ .   (Eq.13) 499 
Procedures were written in Igor Pro 6.22 (Wavemetrics, Oregon) to numerically solve the set 500 
of 10 differential equations describing the transitions between the 10 states of the model at 501 
different voltages and in the presence of different ligand concentrations. Briefly, to fit the 502 
gating behavior during voltage steps, eigenvalues and corresponding eigenvectors of the 503 
transition matrix were numerically solved using the MatrixEigenV operation, and used to 504 
calculate the sums of exponential terms describing the time-dependent changes of the 505 
probabilities that the channel is in one of the 10 states. The FuncFit and DoNewGlobalFit 506 
procedures were then used to find the model parameters that yield the best global fit to current 507 
relaxation time courses measured within one cell in the absence and presence of ligand (Table 508 
1). The global kinetic fit included three free parameters: ߙ଴(0), ߚ଴(0) and kon. Prior to the 509 
kinetic fit, Kd,ligand and ΔΔGligand were determined from steady-state currents, according to 510 
Equation 9; koff was set as Kd × kon; z was fixed at a value of 0.82, based on earlier work 511 
(Voets et al., 2007). We further assumed that the rate of ligand binding to the open and closed 512 
state of the channel were identical, whereas the rate of ligand unbinding from the closed state 513 
was constrained by detailed balance. The integrateODE operation was used to model TRPM8 514 
currents during voltage steps or action potential waveforms, using mean parameters obtained 515 
from the fits (Table 1).  516 
Statistics 517 
Data analysis was performed using Origin 9.0 (OriginLab Corporation, Northampton). Group 518 
data are presented as mean ± SEM from n cells. Comparison between two groups was done 519 
using Student’s unpaired or paired test, as indicated. No explicit power analysis was 520 
performed prior to the experiments to determine sample size, since we had no means to 521 
reliably estimate the size and variability of the effects of the ligands on parameters of TRPM8 522 
gating. For patch-clamp experiments on HEK cells, typically 5-10 cells were measured for 523 
each condition, thereby limiting the SEM to ≤20% of the mean value for the relevant 524 
parameters. For the calcium imaging experiments on mouse TG neurons, a maximal number 525 
of neurons from nine mice isolated on 5 independent days were analyzed. Since highly 526 
significant results were obtained from this set of experiments, no further animals were 527 
sacrificed. 528 
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Figure titles and legends: 673 
Figure 1. AITC excites trigeminal neurons in a TRPM8-dependent manner.  674 
A, Examples of fura-2-based intracellular calcium measurements in trigeminal neurons from 675 
TRPV1/TRPA1 double knockout mice. The red trace represents a neuron that shows 676 
responses to AITC (3 mM) and menthol (50 µM), which can be reversible inhibited by 677 
AMTB (2 µM). The black trace represents a non-responder. A high K+-solution (50 mM K+) 678 
was used at the end of the experiments to identify neurons from non-neuronal cells. In total, 679 
578 neurons from 6 different mice were analyzed. B, Percentage of AITC-responsive neurons 680 
in menthol-sensitive (n=55) and menthol-insensitive (n=523) neurons. C, Quantification of 681 
the reversible inhibition by AMTB of responses to AITC and menthol (n=54).  682 
Figure 2. AITC activates human TRPM8.  683 
A, Time course of whole-cell currents at +100 and -80 mV in HEK293 cells expressing 684 
human TRPM8, upon stimulation with the indicated concentrations of AITC. B, Current-685 
voltage relations recorded at the time points indicated in (A). C, Relative AITC-induced 686 
current increase at +100 and -80 mV (n=9). D, Menthol (50 µM) and AITC (3 mM) activate 687 
TRPM8 in cell-free inside-out patches during repetitive 100-ms voltage steps to +100 mV. 688 
Comparable current activation was measured in 5 out of 5 inside-out patches. E, Current 689 
traces recorded at the time points indicated in (D). F, TIRF images showing mCherry-tagged 690 
human TRPM8 in the perimembrane region before and during stimulation with 3 mM AITC. 691 
Micrographs are 20 μm × 20 μm. G, Lack of change in perimembrane mCherry-fluorescence 692 
during stimulation with AITC (n=6). Fluorescence was normalized to the total fluorescence 693 
before adding AITC to the bath solution. 694 
 695 
Figure 3. Voltage dependence of the activating effect of AITC on human TRPM8.  696 
A, TRPM8 currents in response to the indicated voltage step protocol in the absence and 697 
presence of AITC (1 mM). B, Voltage-dependent activation curves in control and in the 698 
presence of the indicated AITC concentrations, for the cell shown in (A). Steady-state 699 
conductance (G) was determined as steady-state current divided by test voltage, and 700 
normalized to the estimated maximal conductance (Gmax), which was obtained by fitting a 701 
Boltzmann function to the curve in the presence of 10 mM AITC. C, Concentration 702 
dependence of the shift of voltage-dependent activation curves (n=7). 703 
Figure 4. Differential effects of AITC and menthol on gating kinetics of human TRPM8.  704 
A, Current traces in response to the indicate voltage protocol in control condition and in the 705 
presence of menthol (30 μM) and AITC (3 mM). The dashed lines overlaying the control and 706 
AITC traces represent single exponential fits, the dotted line overlaying the menthol trace 707 
represents a double exponential fit. B, Scaled and expanded currents corresponding to the 708 
boxed areas in (A). C,D, Current traces in response to the voltage protocol from (A) in control 709 
condition and the indicated concentrations (in μM) of AITC and menthol. E, Mono-710 
exponential time constants for current relaxation at +120 and -80 mV in the presence of 711 
indicated concentrations of AITC (n = 8). Solid lines represent model predictions, obtained by 712 
fitting a mono-exponential function to simulated currents like those shown in Figure 5D. F, 713 
Fast and slow exponential time constants for current relaxation at +120 mV and -80 mV in the 714 
presence of indicated concentrations of menthol (n = 5). Solid lines represent model 715 
predictions, obtained by fitting a double exponential function to simulated currents like those 716 
shown in Figure 5E. See Figure 4 – Figure Supplement 2 for more details on the curve fitting.  717 
Figure 5. Type I (menthol-like) versus Type II (AITC-like) TRPM8 agonists.  718 
A, (left) Energy diagram for the transition between the closed and open channel conformation 719 
in a non-liganded channel. Steady-state equilibrium is determined by ΔG0, whereas Eopen and 720 
Eclose determine the opening and closing rates, respectively. (right) Alteration in the energy 721 
profile upon binding of Type I and Type II ligands. The black line represents the non-liganded 722 
channel, whereas the green lines represent channels with 1-4 bound ligands. The 723 
corresponding kinetic schemes are provided in Supplementary Figure 2. B,C, Activation (B) 724 
and deactivation (C) time courses in the absence and presence of the indicated concentrations 725 
of menthol or AITC. Overlaid dashed lines represent global fits to the control and ligand-726 
activated current traces. D,E, Model predictions corresponding to the experimental data 727 
shown in Figure 4C,D. 728 
Figure 6. TRPM8 gating during an action potential – Type I versus Type II ligands.  729 
A, Voltage protocol simulating a sensory neuron action potential (left); TRPM8 currents in 730 
HEK293 cells in response to the action potential waveform in control condition and during 731 
application of menthol (30 μM) and AITC (3 mM) (middle); and corresponding model 732 
simulation (right). Boxed areas are expanded in the inset. B, Peak outward and inward 733 
currents during the action potential waveform in the presence of menthol (cyan) and AITC 734 
(magenta; n=6). C, Ratio between peak inward and peak outward current in the presence of 735 
menthol or AITC. ***, p<0.001. D, TRPM8 current responses during a train of action 736 
potentials (1 s; 8Hz) in control condition and during application of menthol and AITC (top); 737 
outward (middle) and inward (bottom) charge displacement during the action potential train, 738 
determined as the integrated current after subtraction of the holding current. E, Mean inward 739 
and outward charge displacement for the two ligands (n=5). *, p<0.05; **, p<0.01. 740 
 741 
Figure 7. Differential effectiveness of Type I and Type II agonists in excitable versus 742 
non-excitable cells.  743 
A, Fura-2-based intracellular calcium measurements in mouse trigeminal neurons from 744 
TRPV1/TRPA1 double knockout mice showing increases in intracellular  calcium in response 745 
to AITC (3 mM) and menthol (30 µM). The upper trace shows the time differential of the 746 
intracellular calcium concentration, which represents a measure of net calcium 747 
influx/extrusion mechanisms. The TRPM8-dependence of the responses was ensured based on 748 
full block by AMTB (as in Figure 1; not shown). B, Same as (A), but in the presence of TTX 749 
(1 μM) to block neuronal action potentials. C, Same as (A), but in a HEK293 cell expressing 750 
mouse TRPM8. Non-transfected cells did not show any detectable response to AITC or 751 
menthol. C, Relative stimulatory effect of menthol and AITC in control trigeminal neurons 752 
(n=81 from 9 different mice), trigeminal neurons treated with 1 μM TTX (n=3 from 3 753 
different mice) and HEK293 cells (n=448). *, **, ***: P < 0.05, 0.01 and 0.001, respectively, 754 
in paired t-test comparing the response to AITC and menthol within individual cells. ###: P < 755 
0.001 in unpaired t-tests comparing TG neurons and HEK293 cells.   756 
Tables: 757 
Table 1. Experimentally derived model parameters describing the action of menthol and 758 
AITC on TRPM8 gating. 759 
Displayed are values for the different parameters that determine the MWC model. For the 760 
global kinetic fits, cells were included for which current traces were fit at minimally tree 761 
ligand concentrations and two voltages. More details are provided in the text.  762 
 763 
  764 
Parameter Value Source 
z 0.82 (Voets et al., 2007) 
߂߂ܩ஺ூ்஼  -2.7 ± 0.4 kJ mol-1 Steady-state activation curves (n=7) 
߂߂ܩ௠௘௡௧௛௢௟ -4.5 ± 0.4 kJ mol-1 Steady-state activation curves (n=6) 
Kd,AITC 2.9 ± 0.6 mM Steady-state activation curves (n=7) 
Kd,menthol 21 ± 4 μM Steady-state activation curves (n=6) 
ߙ଴(0) 10.4 ± 1.2  s-1 Global kinetic fit (n=14) 
ߚ଴(0) 1.11 ± 0.15 ×103 s-1 Global kinetic fit (n=14) 
kon,AITC 95 ± 35 ×103 M-1 s-1 Global kinetic fit (n=7) 
kon,menthol 551 ± 210 ×103 M-1 s-1 Global kinetic fit (n=7) 
Figure supplements: 765 
Figure 4 – Figure supplement 1.  766 
A,B Examples of mono-exponential (A) and bi-exponential (B) fits to experimental relaxation 767 
time courses in the presence of different concentrations of menthol (left), along with the 768 
corresponding residual plots (right). The data are from Figure 4D, relaxation time course at 769 
+120 mV. C, Mono-exponential and bi-exponential fits to modeled relaxation time courses at 770 
+120 mV as in Figure 5E (left). Bi-exponential fits virtually overlap with the modeled data, as 771 
can be appreciated from the corresponding residual plots (right). D, Comparison of mono-772 
exponential time constants at -80 mV (red) and =120 mV (black) obtained from fits to 773 
experimental (symbols) and modeled (lines) relaxation time courses.   774 
Figure 4 – Figure supplement 2.  775 
A-C, Same approach as in Figure 4, showing the effects of thymol (A; 500 μM), icilin (B; 10 776 
μM) and linalool (C; 500 μM). D, Effect of thymol, icilin and linalool on the time constant of 777 
current relaxation at +120 and -80 mV; n=5 for each ligand, obtained by fitting a 778 
monoexponential function to the data.  779 
Figure 5 – Figure supplement 1.   780 
Kinetic schemes of the MWC model, depicting the differential effects of Type I and Type II 781 
ligands.  782 
Figure 5 – Figure supplement 2. 783 
Combining Type I and Type II agonists. A, Combined effect of menthol and AITC on TRPM8 784 
gating kinetics, using the voltage protocol shown in Figure 4A. B, Model simulation of the 785 
combined effect menthol and AITC. To obtain these traces, the effect of AITC was modeled 786 
as a fixed decrease of ߂ܩ଴ ௠௏ఈற . C, Energy profiles upon simultaneous binding of Type I (top) 787 
and Type II (bottom) ligands.  788 
Figure 6 – Figure supplement 1.  789 
Activation of mouse TRPM8 by AITC. A, TRPM8 currents in response to the voltage step 790 
protocol shown in Figure 3A in the absence and presence of AITC (3 mM). B, Voltage-791 
dependent activation curves corresponding to the currents shown in (A). C, Current traces in 792 
response to the voltage protocol shown in Figure 4A, in control condition and in the presence 793 
of menthol (30 μM) and AITC (3 mM). (right) Scaled and expanded currents corresponding 794 
to the boxed areas. 795 
Figure 6 – Figure supplement 2.  796 
AITC-induced current inhibition in human versus mouse TRPM8, as well as in chimeric 797 
channels. A,B, Time courses of whole-cell currents at +100 and -80 mV in HEK293 cells 798 
expressing human (left) or mouse (right) TRPM8, upon sequential (A) or simultaneous (B) 799 
stimulation with menthol (50 µM) and AITC (3 mM). C,D, Quantification of the AITC-800 
induced current inhibition in mouse and human TRPM8, as well as in the depicted chimeric 801 
channels containing all possible combinations of transmembrane region and N and C termini 802 
of both orthologues. In (C), inhibition was quantified as I60s/Ipeak, which represents the 803 
remaining current after a 60-s application of 3 mM AITC divided by the peak AITC-induced 804 
current. In (D), inhibition was quantified as I60s/Imenthol, which represents the remaining current 805 
after a 60-s application of 3 mM AITC divided by the peak current induced by menthol (50 806 
µM). Mean ± SEM for 5-8 cells for each chimeric channel. 807 
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 809 







